UCSF/UCB Joint Graduate Group in Bioengineering, University of California, San Francisco, CA, USA.
Neuro Oncol. 2011 Nov;13(11):1192-201. doi: 10.1093/neuonc/nor122. Epub 2011 Aug 24.
The apparent diffusion coefficient (ADC) determined from MR diffusion tensor imaging (DTI) has shown promise for distinguishing World Health Organization grade II astrocytoma (AS) from the more prognostically favorable grade II oligodendroglioma (OD). Since mixed oligoastrocytomas (OAs) with codeletions in chromosomes 1p and 19q confer prognoses similar to those of OD, we questioned whether a previously determined ADC-based criterion for distinguishing OD and AS would hold on an independent set of gliomas that included OA with codeleted or intact 1p/19q chromosomes. We also questioned whether the ADC is associated with the tumor microstructure. ADC colormaps generated from presurgical DTI scans were used to guide the collection of biopsies from each tumor. The median normalized ADC distinguished OD from AS with 91% sensitivity and 92% specificity. 1p/19q codeleted OAs were always classified as ODs, while 1p/19q intact OAs were always classified as ASs. There were positive associations between the ADC and both the SMI-31 score of axonal disruption and the fraction of tumor cells in the biopsies. The ADC of OD and 1p/19q codeleted OA was more associated with tumor fraction, while the ADC of AS and 1p/19q intact OA was more associated with SMI-31 score. We conclude that our previously determined threshold median ADC can distinguish grade II OD and AS on a new patient cohort and that the distinctions extend to OA with codeleted and intact 1p/19q chromosomes. Further, the ADC in grade II gliomas is associated with the fraction of tumor cells and degree of axonal disruption in tumor subregions.
表观扩散系数 (ADC) 由磁共振弥散张量成像 (DTI) 确定,已显示出有望区分世界卫生组织 (WHO) 二级星形细胞瘤 (AS) 和预后较好的二级少突胶质细胞瘤 (OD)。由于 1p 和 19q 染色体缺失的混合少突星形细胞瘤 (OA) 具有与 OD 相似的预后,我们质疑是否之前基于 ADC 区分 OD 和 AS 的标准是否适用于包括 1p/19q 染色体缺失或完整的 OA 的独立胶质瘤组。我们还质疑 ADC 是否与肿瘤微结构有关。术前 DTI 扫描生成的 ADC 彩色图用于指导从每个肿瘤采集活检。归一化 ADC 中位数可区分 OD 和 AS,敏感性为 91%,特异性为 92%。1p/19q 缺失的 OA 始终被归类为 OD,而 1p/19q 完整的 OA 始终被归类为 AS。ADC 与轴索破坏的 SMI-31 评分和活检中肿瘤细胞的比例之间存在正相关。OD 和 1p/19q 缺失的 OA 的 ADC 与肿瘤分数的相关性更强,而 AS 和 1p/19q 完整的 OA 的 ADC 与 SMI-31 评分的相关性更强。我们的结论是,我们之前确定的阈值中位数 ADC 可以在新的患者队列中区分二级 OD 和 AS,并且这种区分扩展到 1p/19q 染色体缺失和完整的 OA。此外,二级胶质瘤中的 ADC 与肿瘤细胞的比例和肿瘤亚区轴索破坏的程度有关。